Clonality of multifocal urothelial carcinomas: 10 Years of molecular genetic studies

International Journal of Cancer

Volumn 101, Issue 1, 2002, Pages 1-6

  Hafner, Christian ^a   Knuechel, Ruth ^a   Stoehr, Robert ^a   Hartmann, Arndt ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Clonality; Field cancerization; Intraepithelial migration; Intraluminal seeding; Multifocal urothelial carcinoma

Indexed keywords

ADVANCED CANCER; CANCER CELL CULTURE; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; CELL CLONE; CELL MIGRATION; CLONAL VARIATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOTHESIS; INVASIVE CARCINOMA; MOLECULAR GENETICS; PRIORITY JOURNAL; SHORT SURVEY; THEORY; UROGENITAL TRACT CANCER; UROTHELIUM;

ANIMALS; CELL MOVEMENT; CLONE CELLS; GENE EXPRESSION PROFILING; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM SEEDING; NEOPLASMS, MULTIPLE PRIMARY; TUMOR SUPPRESSOR PROTEIN P53; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 0036722955     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10544     Document Type: Short Survey

References (80)

1. Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders
2. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
3. Field cancerization of the oral cavity: Comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions
4. Widely dispersed p53 mutation in respiratory epithelium
5. Evolution of neoplastic cell lineages in Barrett oesophagus
6. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis
7. Bladder cancer - Field versus clonal origin
8. "Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin
9. Clonal origin bladder cancer
10. Identification of p53 gene mutations in bladder cancers and urine samples
11. Microsatellite alterations as clonal markers for the detection of human cancer
12. Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers
13. Detection of bladder cancer recurrence by microsatellite analysis of the urine
14. Cancer-susceptibility genes. Gatekeepers and caretakers
15. X-chromosome inactivation and development patterns in mammals
16. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation
17. The role of DNA methylation in cancer
18. PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies
19. Field cancerization, clonality, and epithelial stem cells: The spread of mutated clones in epithelial sheets
20. Mosaicism in human epithelium: Macroscopic monoclonal patches cover the urothelium
21. Evidence for oligoclonality and intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract
22. Role of chromosome 9 in human bladder cancer
23. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract
24. Four tumor suppressor loci on chromosome 9q in bladder cancer: Evidence for two novel candidate regions at 9q22.3 and 9q31
25. Molecular genetics in carcinoma of the bladder
26. Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome-9 deletion
27. Metachronous multifocal development of urothelial cancers by intraluminal seeding
28. p53 mutations in multiple urothelial carcinomas: A molecular analysis of the development of multiple carcinomas
29. Frequent association of p53 gene mutation in invasive bladder cancer
30. Two molecular pathways to transitional cell carcinoma of the bladder
31. Allelic loss of chromosome 17p in urothelial cancer: Strong association with invasive phenotype
32. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
33. Hepatocellular carcinoma p53 G→T transversions at codon 249: The fingerprint of aflatoxin exposure?
34. Specific p53 gene mutations in urinary bladder urothelium after the Chernobyl accident
35. IARC database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualisation tools
36. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells
37. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: Evidence of intraluminal tumour seeding
38. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
39. The clonal evolution of tumor cell populations
40. Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of p53 and retinoblastoma proteins
41. Identical clonal origin of synchronous and metachronous low-grade, noninvasive papillary transitional cell carcinomas of the urinary tract
42. Clonality and genetic divergence in multifocal lowgrade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis
43. Allelic losses demonstrate monoclonality of multifocal bladder tumors
44. Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors
45. Genetic alterations in TP53 in recurrent urothelial cancer: A longitudinal study
46. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
47. E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells
48. Molecular diagnosis of metastatic origin in a patient with metachronous multiple cancers of the renal pelvis and bladder
49. Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder
50. C-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder
51. p53 mutations in phenacetin-associated human urothelial carcinomas
52. Clonal analysis of phenacetin-implicated urothelial carcinoma
53. Evaluation of DNA flow cytometry as a screening test for bladder cancer
54. Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma
55. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinomas
56. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings
57. Multifocal transitional cell cancer and p53 mutation analysis
58. Morphological changes of urothelial and intestinal mucosa after ureterosigmoidostomy during experimental urogenic carcinogenesis
59. Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma
60. Urothelial susceptibility to tumor cell implantation: Influence of cauterization
61. Intravesical recombinant tissue plasminogen activator for the prevention of implantation-mediated bladder tumor recurrence
62. Bladder cancer recurrence by implantation of exfoliated cells: Is gammalinolenic acid an effective tumoricidal agent?
63. Clonal analysis of urothelial carcinomas in C3H/HeN→BALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine
64. Biopsy of apperently normal urothelium in patients with bladder carcinoma
65. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia
66. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: Implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer
67. Multifocality of transitional cell carcinoma results from genetic instability of entire transitional epithelium
68. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma
69. Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder
70. Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer
71. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
72. Multiple oral squamous lesions: Are they genetically related?
73. p53 gene mutation in recurrent superficial bladder cancer
74. Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis
75. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder
76. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
77. Drug metabolizing enzyme polymorphisms as risk factors of individual susceptibility to bladder cancers
78. Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor
79. Some tumors of the bladder are polyclonal in origin
80. Histological typing of urinary bladder tumours